See every side of every news story

Published 17 days ago • loading... • Updated 17 days ago

AbbVie reports topline data from Phase I ABBV-295 trial

Summary by Clinical Trials Arena

AbbVie has reported positive topline data from the multiple ascending dose (MAD) section of its Phase I trial of ABBV-295 for weight loss.The post AbbVie reports topline data from Phase I ABBV-295 trial appeared first on Clinical Trials Arena.

This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

2 Articles

2 Articles

Clinical Trials Arena

Reposted by

Verdict Hospital

AbbVie reports topline data from Phase I ABBV-295 trial

AbbVie has reported positive topline data from the multiple ascending dose (MAD) section of its Phase I trial of ABBV-295 for weight loss.The post AbbVie reports topline data from Phase I ABBV-295 trial appeared first on Clinical Trials Arena.

17 days ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Coverage Details

Total News Sources2

Leaning Left0Leaning Right0Center0Last Updated16 days agoBias Distribution

No sources with tracked biases.

Bias Distribution

There is no tracked Bias information for the sources covering this story.

Untracked bias

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Clinical Trials Arena broke the news in 17 days ago on Tuesday, March 10, 2026.

Sources are mostly out of (0)

Similar News Topics

Stories disproportionately reported by the Left or the Right

Similar News Topics